This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yagi, K. Articles by Iwao, H. Search for Related Content PubMed PubMed Citation Articles by Yagi, K. Articles by Iwao, H.

(Hypertension. 1997;29:728-735.)
© 1997 American Heart Association, Inc.

Articles

Characteristics of Diabetes, Blood Pressure, and Cardiac and Renal Complications in Otsuka Long-Evans Tokushima Fatty Rats

Keiko Yagi; Shokei Kim; Hideki Wanibuchi; Tatsuya Yamashita; Yoshitaka Yamamura; Hiroshi Iwao

the Department of Pharmacology (K.Y., S.K., H.I.) and First Department of Pathology (H.W.), Osaka City University Medical School, and the Second Tokushima Institute of New Drug Research (T.Y., Y.Y.), Otsuka Pharmaceutical Co, Ltd, Tokushima, Japan.

Correspondence to Shokei Kim, MD, Department of Pharmacology, Osaka City University Medical School, 1-4-54 Asahimachi, Abeno, Osaka 545, Japan.

To characterize the molecular mechanism of cardiac and renal complications in non–insulin-dependent diabetes mellitus (NIDDM), we examined the gene expression of Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a new animal model for human NIDDM, at the ages of 14 weeks (prediabetic stage), 30 weeks (NIDDM stage), and 54 weeks (IDDM stage). Tissue mRNA levels were measured by Northern blot analysis. In 14-week-old OLETF rats, cardiac mRNAs for transforming growth factor-ß₁ (TGF-ß₁) and extracellular matrix, including collagen types I, III, and IV and laminin, were significantly increased compared with control rats (Long-Evans Tokushima Otsuka rats). Cardiac ß-myosin heavy chain (MHC) mRNA of OLETF was increased at 30 and 54 weeks of age, whereas -MHC mRNA of OLETF was inversely decreased at 54 weeks. Marked perivascular fibrosis was seen in the hearts of OLETF rats from 30 weeks of age. In the kidney of OLETF rats, glomerular TGF-ß₁ expression was temporally increased at 30 weeks of age, followed by glomerulosclerosis characterized by mesangial proliferation, thickening of the basement membrane, and nodular lesions. Blood pressure of OLETF rats remained higher than that of control rats from the prediabetic stage to the IDDM stage. Thus, in OLETF rats, cardiac fibrosis–related gene expressions were already enhanced at the prediabetic stage, which supports the involvement of these gene expressions in cardiac perivascular fibrosis. The antithetical change in ß- and -MHC expressions seems to participate in the decreased cardiac contractility seen in diabetes. Furthermore, TGF-ß₁ may also contribute to glomerulosclerosis of OLETF rats. OLETF rats seem to be a useful model to study the mechanism of hypertension and cardiac and renal complications in NIDDM.

Key Words: diabetes mellitus • heart • nephropathy, diabetic • transforming growth factor • blood pressure

This article has been cited by other articles:

				D. A. Nugent, D. M. Smith, and H. B. Jones A Review of Islet of Langerhans Degeneration in Rodent Models of Type 2 Diabetes Toxicol Pathol, June 1, 2008; 36(4): 529 - 551. [Abstract] [Full Text] [PDF]

				K. A. Griffin, M. Abu-Naser, I. Abu-Amarah, M. Picken, G. A. Williamson, and A. K. Bidani Dynamic blood pressure load and nephropathy in the ZSF1 (fa/facp) model of type 2 diabetes Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1605 - F1613. [Abstract] [Full Text] [PDF]

				Y. Minamiyama, Y. Bito, S. Takemura, Y. Takahashi, S. Kodai, S. Mizuguchi, Y. Nishikawa, S. Suehiro, and S. Okada Calorie Restriction Improves Cardiovascular Risk Factors via Reduction of Mitochondrial Reactive Oxygen Species in Type II Diabetic Rats J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 535 - 543. [Abstract] [Full Text] [PDF]

				T Hayashi, K Sohmiya, A Ukimura, S Endoh, T Mori, H Shimomura, M Okabe, F Terasaki, and Y Kitaura Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart Heart, October 1, 2003; 89(10): 1236 - 1242. [Abstract] [Full Text] [PDF]

				R. Candido, J. M. Forbes, M. C. Thomas, V. Thallas, R. G. Dean, W. C. Burns, C. Tikellis, R. H. Ritchie, S. M. Twigg, M. E. Cooper, et al. A Breaker of Advanced Glycation End Products Attenuates Diabetes-Induced Myocardial Structural Changes Circ. Res., April 18, 2003; 92(7): 785 - 792. [Abstract] [Full Text] [PDF]

				S. Jesmin, Y. Hattori, I. Sakuma, C. N. Mowa, and A. Kitabatake Role of ANG II in coronary capillary angiogenesis at the insulin-resistant stage of a NIDDM rat model Am J Physiol Heart Circ Physiol, October 1, 2002; 283 (4): H1387 - H1397. [Abstract] [Full Text] [PDF]

				M. Iwase, Y. Uchizono, K. Tashiro, D. Goto, and M. Iida Islet Hyperperfusion During Prediabetic Phase in OLETF Rats, a Model of Type 2 Diabetes Diabetes, August 1, 2002; 51(8): 2530 - 2535. [Abstract] [Full Text] [PDF]

				J. S. Stern, M. D. Gades, C. M. Wheeldon, and A. T. Borchers Calorie Restriction in Obesity: Prevention of Kidney Disease in Rodents J. Nutr., March 1, 2001; 131(3): 913S - 917. [Abstract] [Full Text]

				Li Yao, K. Mizushige, T. Noma, K. Murakami, K. Ohmori, and H. Matsuo Improvement of Left Ventricular Diastolic Dynamics in Prediabetic Stage of A Type II Diabetic Rat Model After Troglitazone Treatment Angiology, January 1, 2001; 52(1): 53 - 57. [Abstract] [PDF]

				S. Kim and H. Iwao Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases Pharmacol. Rev., March 1, 2000; 52(1): 11 - 34. [Abstract] [Full Text] [PDF]

				K. Mizushige, L. Yao, T. Noma, H. Kiyomoto, Y. Yu, N. Hosomi, K. Ohmori, and H. Matsuo Alteration in Left Ventricular Diastolic Filling and Accumulation of Myocardial Collagen at Insulin-Resistant Prediabetic Stage of a Type II Diabetic Rat Model Circulation, February 29, 2000; 101(8): 899 - 907. [Abstract] [Full Text] [PDF]

				G. J. Schwartz, A. Whitney, C. Skoglund, T. W. Castonguay, and T. H. Moran Decreased responsiveness to dietary fat in Otsuka Long-Evans Tokushima fatty rats lacking CCK-A receptors Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1999; 277(4): R1144 - R1151. [Abstract] [Full Text] [PDF]

				Y. M Pinto, M. Paul, and D. Ganten Lessons from rat models of hypertension: from Goldblatt to genetic engineering Cardiovasc Res, July 1, 1998; 39(1): 77 - 88. [Abstract] [Full Text] [PDF]

				S. Kim, H. Wanibuchi, A. Hamaguchi, K. Miura, S. Yamanaka, and H. Iwao Angiotensin Blockade Improves Cardiac and Renal Complications of Type II Diabetic Rats Hypertension, November 1, 1997; 30(5): 1054 - 1061. [Abstract] [Full Text]

				H. Yoshikawa, Y. Kihara, M. Taguchi, T. Yamaguchi, H. Nakamura, and M. Otsuki Role of TGF-beta 1 in the development of pancreatic fibrosis in Otsuka Long-Evans Tokushima Fatty rats Am J Physiol Gastrointest Liver Physiol, March 1, 2002; 282(3): G549 - G558. [Abstract] [Full Text] [PDF]